Polypharmacy in Clozapine-resistant Schizophrenia

NCT00918021 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: olanzapine
DRUG: placebo

Sponsor

Niuvanniemi Hospital